3SBIO(01530),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01530 3SBIO

Market Closed 08-28 16:08:33

16.960

-0.190

-1.11%

High17.400	Low16.840	Vol18.78M
Open17.260	D1 Closing17.150	Amplitude3.27%
Mkt Cap42.91B	Tradable Cap42.91B	Total Shares2.53B
T/O320.58M	T/O Rate0.74%	Tradable Shares2.53B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"3SBIO","latestPrice":16.96,"timestamp":1787904513005,"preClose":17.15,"halted":0,"volume":18779072,"delay":0,"changeRate":-0.01107871720116605,"floatShares":2530000000,"shares":2530000000,"eps":3.995561645339355,"marketStatus":"Market Closed","change":-0.19,"latestTime":"08-28 16:08:33","open":17.26,"high":17.4,"low":16.84,"amount":320582694,"amplitude":0.032653,"askPrice":16.97,"askSize":52000,"bidPrice":16.96,"bidSize":8000,"shortable":3,"etf":0,"ttmEps":3.7847252928976918,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":7,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":17.15,"dividendRate":0.015434,"openAndCloseTimeList":[[1787880600000,1787889600000],[1787893200000,1787904000000]],"volumeRatio":0.5340064642064867,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01530","defaultTab":"news","newsList":[{"id":"1167323330","title":"CICC Keeps Outperform Rating on 3SBIO, Trims Target Price to HK$30.00","url":"https://stock-news.laohu8.com/highlight/detail?id=1167323330","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167323330?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:44","pubTimestamp":1787543093,"startTime":"0","endTime":"0","summary":"CICC has released a research report noting that, considering internal business pressures, it has cut its 2026/2027 net profit forecasts for 3SBIO by 6% and 12% to RMB 2.842 billion and RMB 3.051...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1161","HK0000165453.HKD","EWH","01530","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661295126","title":"3SBio (SEHK:1530) Stock Sees Margin Strength Clash With Profit Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2661295126","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661295126?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:20","pubTimestamp":1787318409,"startTime":"0","endTime":"0","summary":"3SBio stock closed at HK$17.83 on Friday, roughly flat over the past month, even as the latest half year numbers landed with a heavy focus on profitability. The headline is simple. H1 2026 brought in C¥4,525.985m of revenue, yet the story that matters is margin strength and what that might mean for future earnings power.\nInvestors now face a time horizon test. Trailing earnings growth and a P/E around 4.6x paint one picture. Forecasts that point to declining revenue and earnings over the next...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1530/3sbio-shares/news/3sbio-sehk1530-stock-sees-margin-strength-clash-with-profit","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1530/3sbio-shares/news/3sbio-sehk1530-stock-sees-margin-strength-clash-with-profit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FEBU","VGFPF","RGLO","DECU","BK1583","BK1593","BK1161","HK0000165453.HKD","PMDE","JOYT","VOTE","01530","GXDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250205","title":"3SBio H1 FY26 Net Profit Rises 26.5% to RMB 1.44 Billion; Revenue Increases 3.9% to RMB 4.53 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250205","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250205?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:25","pubTimestamp":1787297118,"startTime":"0","endTime":"0","summary":"3SBio H1 FY26 net profit rises 26.5% to RMB 1.44 billion; revenue increases 3.9% to RMB 4.53 billion3SBio posted first-half 2026 revenue of RMB 4.53 billion, up 3.9% year over year.Net profit attribut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLb6tQZj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1583","BK1161","HK0000165453.HKD","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250247","title":"Press Release: 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250247?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:24","pubTimestamp":1787297040,"startTime":"0","endTime":"0","summary":"SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- 3S Bio (01530.HK) today announced its interim results for the first half of 2026. During the period, the Company recorded revenue of RMB 4.53 billion, represent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4232","GDOC","MEDX","R","BK4022","BK1593","NVIB","IDNA","HK0000165453.HKD","BK1583","BMED","HYLG","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100118644","title":"Morning Market Pulse: Hang Seng Index Climbs 0.72% in Early Session, Lithium Miners Lead Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1100118644","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100118644?lang=en_us&edition=fundamental","pubTime":"2026-08-21 12:09","pubTimestamp":1787285378,"startTime":"0","endTime":"0","summary":"Hong Kong equities advanced in Thursday's morning session, with the benchmark Hang Seng Index adding 184 points to trade 0.72% higher, while the Hang Seng Tech Index gained 0.50%. Total turnover in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07226","BK1511","HLDCY","03032","LU1152091168.USD","SG9999001093.SGD","HK0000252152.HKD","601869","BK1518","HK0000165453.HKD","HSI","LU1152091754.HKD","82800","BK1543","03115","513600","LU0702159699.USD","002466","02600","BK1170","BK1610","HK0000914686.HKD","03423","03033","LU0264606111.USD","HSImain","SG9999006597.SGD","LU0630314457.HKD","BK1500","HK0000252160.HKD","07200","02800","BK1513","03750","LU2279858448.HKD","BK1240","LU0456827905.SGD","601600","01866","LU0287142896.SGD","07300","LU1993786604.SGD","LU1960683339.HKD","03067","BK1175","SG9999003461.SGD","HHImain","03419","LU1719994722.HKD","LU1251922891.USD","07552","09067","BK1559","00189","BK1526","BK1522","BK1117","LU0173614495.USD","LU0359202008.SGD","BK1155","HK0000500386.USD","LU0572939691.SGD","LU0210526637.USD","LU1770034418.SGD","02837","09088","06869","00354","HK0001040143.USD","03037","BK1149","09115","00012","BK1113","LU1808992512.USD","02833","01772","06656","BK1583","BK1568","300750","09696","07500","HK0000286598.CNH","BK1593","BK1207","LU1303224171.USD","BK1589","06896","LU1023057109.AUD","LU1224709979.USD","BK1506","LU0345781412.USD","LU0051755006.USD","BK1116","LU0359201885.HKD","LU0588546209.SGD","002460","BK1509","LU1008478684.HKD","01378","LU1171460220.USD","SG9999014674.SGD","LU0345780950.USD","LU0307460666.USD","03088","BK1586","HK0001040168.HKD","03417","LU0359201612.USD","01530","BK1190","LU0880133367.SGD","LU1807302812.USD","MCHmain","BK1161","02706","BK1601","HK0000914660.USD","LU0469268626.HKD","LU0572940350.SGD","HTImain","HSTECH","BK1592","BK1594","83115","LU0067412154.USD","LU0737861699.HKD","02788","LU1166156734.SGD","BK1523","BK1129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185563343","title":"Hong Kong Stock Alert: 3SBIO Surges Over 7% on Strong First-Half Adjusted Operating Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1185563343","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185563343?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:30","pubTimestamp":1787279417,"startTime":"0","endTime":"0","summary":"3SBIO (01530) shares climbed more than 7% in early trading, with the stock last up 6.85% at HK$17.63, on turnover of HK$395 million. The surge follows the company's release of its 2026 interim...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","01530","BK4585","BK1593","BK4588","HK0000165453.HKD","KCAI","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122017825","title":"Movement Alert｜3SBIO Rises 5.58% in Regular Trading, H1 Adjusted Profit Up 26.5% and New Drug Approval Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1122017825","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122017825?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:46","pubTimestamp":1787276811,"startTime":"0","endTime":"0","summary":"On August 21, 3SBIO rose 5.58% in regular trading, trading at HKD 17.45/share, with turnover of HKD 198 million.On the news front, the company released its H1 interim results on August 20, reporting...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"3SBIO Surges on 26.5% Adjusted Profit Rise and New Drug Nod","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258777","title":"Press Release: Sunshine Guojian Releases 2026 Interim Report:","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258777","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258777?lang=en_us&edition=fundamental","pubTime":"2026-08-21 08:00","pubTimestamp":1787270400,"startTime":"0","endTime":"0","summary":"Innovation-driven, Steady AdvancementSHANGHAI, Aug. 20, 2026 /PRNewswire/ -- Today, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (hereinafter referred to as \"Sunshine Guojian\", stock code: 688","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","688336","BK1161","BK4022","NVIB","IDNA","BK1593","HYLG","01530","BK1583","BK0239","BK4232","HK0000165453.HKD","R","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660384532","title":"China's 3SBio H1 Net Profit Falls on Higher Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2660384532","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660384532?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:37","pubTimestamp":1787236626,"startTime":"0","endTime":"0","summary":"China's 3SBio H1 net profit falls on higher expensesOverviewChina biopharmaceutical firm's half-year revenue rose 3.9% yr/yrNet profit attributable to shareholders fell 15.6% yr/yrGross profit increas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0M8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IE00BZ08YT58.USD","LU0472753341.HKD","BK4149","MADE","LU0689626769.HKD","LU0289961442.SGD","BK1593","LU0289739343.SGD","BK1191","BK4588","BK1589","01177","LU2463526074.USD","BK1583","BK1161","LU0511384066.AUD","IE000M9KFDE8.USD","LU0203347892.USD","BK1521","LU0154245673.USD","IE00BZ08YS42.EUR","LU0069063385.USD","CMI","BK4567","LU0154245756.USD","LU0124676726.USD","BK1515","BK4585","LU0057025933.USD","01530","HK0000165453.HKD","LU0203345920.USD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660591238","title":"3SBio H1 Revenue RMB 4,526 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660591238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660591238?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:28","pubTimestamp":1787236090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLX9N116F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01530","BK1161","BK1593","BK1583","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660047222","title":"China National Medical Products Administration: Approves 3S Guojian's Nonsteroidal Anti-Inflammatory Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2660047222","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660047222?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:58","pubTimestamp":1787191101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nP8N43G01E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01530","HK0000165453.HKD","BK1161","BK1583","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178957286","title":"Movement Alert｜3SBIO Rises 5.15% in Regular Trading, Interim Results Review and Biotech Sector Strength Fuel Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1178957286","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178957286?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:31","pubTimestamp":1787189514,"startTime":"0","endTime":"0","summary":"On August 20, 3SBIO rose 5.15% in regular trading, trading at 17.25 HKD/share, with turnover of approximately 15.81 million HKD. The stock gained momentum as the company's board convened to review...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"3SBIO Rises as Interim Results Review and Biotech Sector Strength Fuel Gains\n","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194605092","title":"Earning Preview: 3SBIO Q2 revenue expected to increase, institutional views are mixed-to-cautious","url":"https://stock-news.laohu8.com/highlight/detail?id=1194605092","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194605092?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:12","pubTimestamp":1786587120,"startTime":"0","endTime":"0","summary":"Abstract 3SBIO plans to release its quarterly results on August 20, 2026 post-Market; this preview compiles last quarter’s metrics and this quarter’s consensus markers around revenue, margins, net...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: 3SBIO Q2 revenue expected to increase, institutional views are mixed-to-cautious","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186914525","title":"Movement Alert｜3SBIO Rises 5.18% in Regular Trading, Interim Results Review Approaching with Broker Top Pick Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=1186914525","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186914525?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:48","pubTimestamp":1786326499,"startTime":"0","endTime":"0","summary":"On August 10, 3SBIO rose 5.18% in regular trading, trading at 18.91 HKD/share, with turnover of approximately HKD 114 million. The rally was driven by multiple catalysts including the upcoming board...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103396765","title":"GRAND PHARMA (00512) Secures FDA Fast Track for Its Independently Developed Global First-in-Class RDC Diagnostic for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1103396765","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103396765?lang=en_us&edition=fundamental","pubTime":"2026-08-09 18:14","pubTimestamp":1786270480,"startTime":"0","endTime":"0","summary":"GRAND PHARMA (00512) announced that its independently developed global first-in-class, investigational radioactive drug conjugate (RDC) for diagnosing solid tumors, GPN01530-2, has received Fast...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000165453.HKD","BK1593","BK4585","BK4588","00512","BK1583","LABU","01530","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150169294","title":"3SBio Schedules 20 August 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1150169294","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150169294?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:46","pubTimestamp":1786092415,"startTime":"0","endTime":"0","summary":"3SBio Inc. has announced that its board of directors will convene on 20 August 2026 to review and approve the unaudited interim results for the six months ended 30 June 2026. The agenda also includes...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661542","title":"3SBio Schedules Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661542","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657661542?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:37","pubTimestamp":1786091878,"startTime":"0","endTime":"0","summary":"3SBio schedules board meeting to review interim results, consider dividend3SBio schedules a board meeting for Aug. 20, 2026 to review unaudited interim results for the six months ended June 30, 2026.I","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL4zl4Lg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1583","BK1593","01530","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166069326","title":"3SBio Issues Additional 0.16 Million Shares After Option Exercise; Total Outstanding Reaches 2.53 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1166069326","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166069326?lang=en_us&edition=fundamental","pubTime":"2026-08-04 17:03","pubTimestamp":1785834211,"startTime":"0","endTime":"0","summary":"3SBio Inc. released its Monthly Return for July 2026, outlining minor adjustments to its share capital structure following the exercise of employee share options. • Authorised Share Capital –...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176721361","title":"Movement Alert｜3SBio Rises 5.51% in Regular Trading, Biotech Sector Rally Combined with Oversold Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1176721361","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176721361?lang=en_us&edition=fundamental","pubTime":"2026-07-20 10:14","pubTimestamp":1784513693,"startTime":"0","endTime":"0","summary":"On July 20, 3SBio rose 5.51% in regular trading, trading at HK$16.96/share, with turnover of approximately HK$162 million.On the news front, the biotechnology sector saw broad-based strength, with...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129482072","title":"Movement Alert｜3SBio Falls 5.64% in Regular Trading, Institutional Selling Compounds Biotech Sector Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=1129482072","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129482072?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:09","pubTimestamp":1784254168,"startTime":"0","endTime":"0","summary":"On July 17, 3SBio fell 5.64% in regular trading, trading at 16.35 HKD/share, with turnover of HKD 357 million.On the news front, Orient Securities sold 6.131 million shares of 3SBio on July 10 at...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3sbio.com","stockEarnings":[{"period":"1week","weight":-0.0488},{"period":"1month","weight":-0.0297},{"period":"3month","weight":-0.0697},{"period":"6month","weight":-0.2156},{"period":"1year","weight":-0.3773},{"period":"ytd","weight":-0.2882}],"compareEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":-0.0086},{"period":"3month","weight":0.016},{"period":"6month","weight":-0.0393},{"period":"1year","weight":0.0234},{"period":"ytd","weight":-0.0018}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. The Company's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The Company is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The Company's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.006634},{"month":2,"riseRate":0.454545,"avgChangeRate":0.001777},{"month":3,"riseRate":0.818182,"avgChangeRate":0.113184},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.011081},{"month":5,"riseRate":0.636364,"avgChangeRate":0.080953},{"month":6,"riseRate":0.727273,"avgChangeRate":0.025359},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.034677},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.011676},{"month":9,"riseRate":0.636364,"avgChangeRate":0.027477},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.018318},{"month":11,"riseRate":0.727273,"avgChangeRate":0.059928},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.045348}],"exchange":"SEHK","name":"3SBIO","nameEN":"3SBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"3SBIO(01530),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest 3SBIO(01530) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"3SBIO,01530,3SBIO股票,3SBIO股票老虎,3SBIO股票老虎国际,3SBIO行情,3SBIO股票行情,3SBIO股价,3SBIO股市,3SBIO股票价格,3SBIO股票交易,3SBIO股票购买,3SBIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"3SBIO(01530),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest 3SBIO(01530) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}